MS, R., S, F., A, J., V, H., A, V., JS, O., . . . S, S. (2026). Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01474-2
Chicago Style (17th ed.) CitationMS, Rana, et al. "Dynamics of BCMA Expression in Patients with Relapsed/refractory Multiple Myeloma Receiving BCMA-directed CAR-T Therapy." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01474-2.
MLA (9th ed.) CitationMS, Rana, et al. "Dynamics of BCMA Expression in Patients with Relapsed/refractory Multiple Myeloma Receiving BCMA-directed CAR-T Therapy." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01474-2.